account_num,net_change,tag,tag_depth,cik
1711,969376000.0,Goodwill,1,842023_BIO-TECHNE CORP
1732,578971000.0,IntangibleAssetsNetExcludingGoodwill,2,842023_BIO-TECHNE CORP
1827,1548347000.0,IntangibleAssetsNetIncludingGoodwill,2,842023_BIO-TECHNE CORP
2041,281576000.0,OtherAssetsNoncurrent,2,842023_BIO-TECHNE CORP
2091,2163883000.0,AssetsNoncurrent,2,842023_BIO-TECHNE CORP
2089,2755360000.0,Assets,1,842023_BIO-TECHNE CORP
2398,-28084000.0,AccountsPayableCurrent,2,842023_BIO-TECHNE CORP
2347,-44021000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,842023_BIO-TECHNE CORP
3017,-4440000.0,OtherLiabilitiesCurrent,2,842023_BIO-TECHNE CORP
3154,-127754000.0,LiabilitiesCurrent,2,842023_BIO-TECHNE CORP
3303,-440000000.0,LongTermDebtAndCapitalLeaseObligations,2,842023_BIO-TECHNE CORP
3379,-97332000.0,OperatingLeaseLiabilityNoncurrent,3,842023_BIO-TECHNE CORP
3796,-189860000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,842023_BIO-TECHNE CORP
3645,-629860000.0,LiabilitiesNoncurrent,2,842023_BIO-TECHNE CORP
3465,-757614000.0,Liabilities,1,842023_BIO-TECHNE CORP
1368,231683000.0,PropertyPlantAndEquipmentNet,4,842023_BIO-TECHNE CORP
1634,102277000.0,OperatingLeaseRightOfUseAsset,2,842023_BIO-TECHNE CORP
868,591477000.0,AssetsCurrent,2,842023_BIO-TECHNE CORP
260,186080000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,842023_BIO-TECHNE CORP
3661,-1584000.0,CommonStockValue,3,842023_BIO-TECHNE CORP
645,148663000.0,CashAndCashEquivalentsAtCarryingValue,3,842023_BIO-TECHNE CORP
577,172402000.0,CashCashEquivalentsAndShortTermInvestments,4,842023_BIO-TECHNE CORP
59,-4920000.0,AllowanceForDoubtfulAccountsReceivableCurrent,3,842023_BIO-TECHNE CORP
229,204570000.0,AccountsReceivableNetCurrent,3,842023_BIO-TECHNE CORP
207,204570000.0,AccountsNotesAndLoansReceivableNetCurrent,4,842023_BIO-TECHNE CORP
320,204570000.0,ReceivablesNetCurrent,3,842023_BIO-TECHNE CORP
455,186080000.0,InventoryNet,2,842023_BIO-TECHNE CORP
3750,-746606000.0,AdditionalPaidInCapital,1,842023_BIO-TECHNE CORP
3834,-1327572000.0,RetainedEarningsAccumulatedDeficit,1,842023_BIO-TECHNE CORP
3316,-1997746000.0,StockholdersEquity,1,842023_BIO-TECHNE CORP
3809,-78016000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,842023_BIO-TECHNE CORP
171,91744000.0,CostOfGoodsAndServicesSold,2,842023_BIO-TECHNE CORP
144,91744000.0,CostOfRevenue,1,842023_BIO-TECHNE CORP
491,23998000.0,ResearchAndDevelopmentExpense,2,842023_BIO-TECHNE CORP
581,23998000.0,OperatingCostsAndExpenses,2,842023_BIO-TECHNE CORP
110,-276935000.0,RevenueFromContractWithCustomerExcludingAssessedTax,2,842023_BIO-TECHNE CORP
2603,-276935000.0,NoninterestIncome,1,842023_BIO-TECHNE CORP
3733,-746606000.0,AdditionalPaidInCapitalCommonStock,2,842023_BIO-TECHNE CORP
757,52164000.0,OtherAssetsCurrent,2,842023_BIO-TECHNE CORP
2841,-5938000.0,TaxesPayableCurrent,2,842023_BIO-TECHNE CORP
2431,179000.0,NetIncomeLossAttributableToNoncontrollingInterest,1,842023_BIO-TECHNE CORP
2710,-24516000.0,DeferredRevenueCurrent,2,842023_BIO-TECHNE CORP
2673,-34891000.0,EmployeeRelatedLiabilitiesCurrent,2,842023_BIO-TECHNE CORP
2764,-24516000.0,ContractWithCustomerLiabilityCurrent,3,842023_BIO-TECHNE CORP
2676,-1750000.0,BusinessCombinationContingentConsiderationLiabilityCurrent,4,842023_BIO-TECHNE CORP
375,23998000.0,ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost,2,842023_BIO-TECHNE CORP
2877,-5938000.0,AccruedIncomeTaxesCurrent,2,842023_BIO-TECHNE CORP
3494,-9394000.0,OtherLiabilitiesNoncurrent,2,842023_BIO-TECHNE CORP
2552,-15937000.0,AccruedLiabilitiesCurrent,2,842023_BIO-TECHNE CORP
3260,-1997746000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,842023_BIO-TECHNE CORP
3917,-2755360000.0,LiabilitiesAndStockholdersEquity,2,842023_BIO-TECHNE CORP
232,-185191000.0,GrossProfit,1,842023_BIO-TECHNE CORP
601,105331000.0,SellingGeneralAndAdministrativeExpense,3,842023_BIO-TECHNE CORP
1112,129329000.0,OperatingExpenses,1,842023_BIO-TECHNE CORP
1264,-55862000.0,OperatingIncomeLoss,1,842023_BIO-TECHNE CORP
2130,-6304000.0,NonoperatingIncomeExpense,1,842023_BIO-TECHNE CORP
3383,-83134000.0,DeferredIncomeTaxLiabilitiesNet,2,842023_BIO-TECHNE CORP
2149,-62166000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,842023_BIO-TECHNE CORP
2399,1435000.0,IncomeTaxExpenseBenefit,1,842023_BIO-TECHNE CORP
1820,-50993000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,842023_BIO-TECHNE CORP
1077,-50993000.0,ProfitLoss,2,842023_BIO-TECHNE CORP
1912,-50993000.0,NetIncomeLoss,1,842023_BIO-TECHNE CORP
2590,-50993000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,842023_BIO-TECHNE CORP
2903,-50993000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,842023_BIO-TECHNE CORP
281,23739000.0,ShortTermInvestments,1,842023_BIO-TECHNE CORP
2257,-49558000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,842023_BIO-TECHNE CORP
